Clinical Trial Update: Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 trial evaluating neoadjuvant conformal radiotherapy plus sorafenib in soft tissue sarcoma of the extremities and body wall have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: University of California, Davis | Conditions: Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-04-10